VentriPoint Diagnostics(DE:5V7)
€0.030.00 (0.00%)
DE:5V7
VentriPoint Diagnostics financials statements
€0.03
At close:0.00 (0.00%)
VentriPoint Diagnostics (5V7) Ratios
0 Followers
VentriPoint Diagnostics Ratios
DE:5V7's free cash flow for Q2 2026 was C$-614.42K. For the 2026 fiscal year, DE:5V7's free cash flow was increased by C$0.00 and operating cash flow was C$-614.42K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.08 | 0.14 | 1.17 | 5.36 | 8.75 |
| Quick Ratio | 0.08 | 0.14 | 1.17 | 5.36 | 8.75 |
| Cash Ratio | 0.01 | 0.02 | 0.93 | 4.91 | 8.54 |
| Solvency Ratio | -0.68 | -1.33 | -2.84 | -3.39 | -3.16 |
| Operating Cash Flow Ratio | -0.35 | -0.99 | -2.72 | -3.92 | -2.90 |
| Short-Term Operating Cash Flow Coverage | -0.64 | -2.50 | -62.95 | -83.02 | -90.97 |
| Net Current Asset Value | C$ -4.24M | C$ -3.17M | C$ -56.89K | C$ 4.24M | C$ 8.29M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 5.51 | 2.48 | 0.22 | 0.08 | 0.02 |
| Debt-to-Equity Ratio | -0.63 | -0.55 | 2.17 | 0.10 | 0.02 |
| Debt-to-Capital Ratio | -1.72 | -1.21 | 0.68 | 0.09 | 0.02 |
| Long-Term Debt-to-Capital Ratio | -0.01 | -0.02 | 0.29 | 0.02 | 0.01 |
| Financial Leverage Ratio | -0.11 | -0.22 | 9.93 | 1.31 | 1.15 |
| Debt Service Coverage Ratio | -0.89 | -3.03 | -37.33 | -56.34 | -80.19 |
| Interest Coverage Ratio | -6.44 | -25.65 | -74.12 | -139.75 | -286.68 |
| Debt to Market Cap | 0.11 | 0.09 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.96 | -0.33 | 0.19 | 0.99 | 2.39 |
| Profitability Margins | |||||
| Gross Profit Margin | 65.96% | 100.00% | 86.28% | 84.80% | 0.00% |
| EBIT Margin | -1515.54% | -5068.02% | -9786.93% | -7107.01% | 0.00% |
| EBITDA Margin | -1481.50% | -5001.96% | -9634.94% | -7022.10% | 0.00% |
| Operating Profit Margin | -1889.37% | -5045.41% | -10024.80% | -7203.96% | 0.00% |
| Pretax Profit Margin | -1807.64% | -5256.85% | -9905.73% | -7148.33% | 0.00% |
| Net Profit Margin | -1778.62% | -5169.14% | -9905.73% | -7148.33% | 0.00% |
| Continuous Operations Profit Margin | -1778.62% | -5169.14% | -9905.73% | -7148.33% | 0.00% |
| Net Income Per EBT | 98.39% | 98.33% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 95.67% | 104.19% | 98.81% | 99.23% | 104.46% |
| Return on Assets (ROA) | -677.90% | -747.63% | -258.68% | -81.53% | -40.66% |
| Return on Equity (ROE) | 77.74% | 164.98% | -2568.15% | -107.01% | -46.57% |
| Return on Capital Employed (ROCE) | 84.96% | 173.38% | -1013.06% | -99.79% | -43.92% |
| Return on Invested Capital (ROIC) | 222.24% | 350.53% | -818.83% | -97.97% | -43.56% |
| Return on Tangible Assets | -677.90% | -747.63% | -258.68% | -81.53% | -40.66% |
| Earnings Yield | -13.82% | -31.08% | -10.53% | -11.57% | -8.15% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.35 | 0.38 | 0.17 | 0.18 | 0.00 |
| Payables Turnover | 0.06 | 0.04 | 0.01 | 0.01 | 0.05 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.47 | 0.52 | 0.20 | 0.22 | 0.00 |
| Asset Turnover | 0.38 | 0.14 | 0.03 | 0.01 | 0.00 |
| Working Capital Turnover Ratio | -0.05 | -0.07 | 0.02 | 0.01 | 0.00 |
| Cash Conversion Cycle | -5381.36 | -8905.18 | -49180.96 | -27663.44 | -7392.33 |
| Days of Sales Outstanding | 269.78 | 963.33 | 2118.76 | 2003.53 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 5651.13 | 9868.50 | 51299.73 | 29666.97 | 7392.33 |
| Operating Cycle | 269.78 | 963.33 | 2118.76 | 2003.53 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 |
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -950973.50 | 0.00 | -739.20 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -950973.50 | 0.00 | -739.20 |
| Operating Cash Flow Coverage Ratio | -0.60 | -2.07 | -9.22 | -9.01 | -19.67 |
| Operating Cash Flow to Sales Ratio | -8.64 | -35.58 | -77.34 | -60.69 | 0.00 |
| Free Cash Flow Yield | -6.71% | -21.39% | -8.22% | -9.82% | -6.62% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.22 | -3.22 | -9.50 | -8.64 | -12.27 |
| Price-to-Sales (P/S) Ratio | 128.71 | 166.31 | 940.63 | 617.87 | 0.00 |
| Price-to-Book (P/B) Ratio | -5.63 | -5.31 | 243.87 | 9.25 | 5.72 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.89 | -4.67 | -12.16 | -10.18 | -15.12 |
| Price-to-Operating Cash Flow Ratio | -14.89 | -4.67 | -12.16 | -10.18 | -15.14 |
| Price-to-Earnings Growth (PEG) Ratio | 0.19 | 0.00 | 29.63 | -0.91 | -0.82 |
| Enterprise Value Multiple | -9.64 | -3.66 | -9.58 | -7.81 | -10.10 |
| Enterprise Value | 25.70M | 17.40M | 45.38M | 37.39M | 38.52M |
| EV to EBITDA | -9.64 | -3.66 | -9.58 | -7.81 | -10.10 |
| EV to Sales | 142.86 | 182.85 | 922.70 | 548.53 | 0.00 |
| EV to Free Cash Flow | -16.53 | -5.14 | -11.93 | -9.04 | -12.23 |
| EV to Operating Cash Flow | -16.53 | -5.14 | -11.93 | -9.04 | -12.24 |
| Tangible Book Value Per Share | -0.02 | -0.02 | 0.00 | 0.03 | 0.06 |
| Shareholders’ Equity Per Share | -0.02 | -0.02 | 0.00 | 0.03 | 0.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 |
| Tax Burden | 0.98 | 0.98 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.19 | 1.04 | 1.01 | 1.01 | 1.00 |
| Research & Development to Revenue | 2.07 | 10.18 | 22.03 | 15.41 | 0.00 |
| SG&A to Revenue | 17.82 | 41.27 | 57.11 | 44.95 | 0.00 |
| Stock-Based Compensation to Revenue | 3.95 | 7.19 | 10.03 | 11.71 | 0.00 |
| Income Quality | 0.49 | 0.69 | 0.78 | 0.85 | 0.81 |
Currency in CAD
